These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22362856)

  • 1. Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes.
    Koyama N; Matsumoto M; Tamaki S; Yoshikawa M; Fujimura Y; Kimura H
    Eur Respir J; 2012 Sep; 40(3):657-64. PubMed ID: 22362856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.
    Yamashita K; Yagi H; Hayakawa M; Abe T; Hayata Y; Yamaguchi N; Sugimoto M; Fujimura Y; Matsumoto M; Taniguchi S
    J Atheroscler Thromb; 2016 Oct; 23(10):1150-1158. PubMed ID: 27052664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
    Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
    J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessively activated plasminogen in human plasma cleaves VWF multimers and reduces collagen-binding activity.
    Togashi K; Suzuki S; Morita S; Ogasawara Y; Imamura Y; Shin Y
    J Biochem; 2020 Oct; 168(4):355-363. PubMed ID: 32343811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
    De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
    Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study.
    Phillips CL; McEwen BJ; Morel-Kopp MC; Yee BJ; Sullivan DR; Ward CM; Tofler GH; Grunstein RR
    Thorax; 2012 Jul; 67(7):639-44. PubMed ID: 22334531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation.
    Park YD; Yoshioka A; Kawa K; Ishizashi H; Yagi H; Yamamoto Y; Matsumoto M; Fujimura Y
    Bone Marrow Transplant; 2002 May; 29(9):789-94. PubMed ID: 12040478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
    Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
    Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischaemia-reperfusion injury with Pringle's maneuver induces unusually large von Willebrand factor multimers after hepatectomy.
    Yoshikawa T; Nomi T; Sakai K; Hayakawa M; Hokuto D; Matsuo Y; Sho M; Matsumoto M
    Thromb Res; 2019 Nov; 183():20-27. PubMed ID: 31518960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress.
    Yagi H; Konno M; Kinoshita S; Matsumoto M; Ishizashi H; Matsui T; Titani K; Fujimura Y
    Br J Haematol; 2001 Dec; 115(4):991-7. PubMed ID: 11843838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
    Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
    PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report.
    Nakanuma S; Miyashita T; Hayashi H; Ohbatake Y; Takamura H; Okazaki M; Yamaguchi T; Sakai S; Makino I; Oyama K; Tajima H; Ninomiya I; Fushida S; Ohta T
    Transplant Proc; 2017 Sep; 49(7):1596-1603. PubMed ID: 28651806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.